Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) FCF Margin (2020 - 2025)

Historic FCF Margin for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to 11.4%.

  • PROCEPT BioRobotics' FCF Margin rose 212300.0% to 11.4% in Q3 2025 from the same period last year, while for Sep 2025 it was 26.58%, marking a year-over-year increase of 252400.0%. This contributed to the annual value of 46.16% for FY2024, which is 516500.0% up from last year.
  • PROCEPT BioRobotics' FCF Margin amounted to 11.4% in Q3 2025, which was up 212300.0% from 22.54% recorded in Q2 2025.
  • PROCEPT BioRobotics' 5-year FCF Margin high stood at 11.4% for Q3 2025, and its period low was 214.1% during Q1 2021.
  • Its 5-year average for FCF Margin is 94.8%, with a median of 101.83% in 2023.
  • In the last 5 years, PROCEPT BioRobotics' FCF Margin soared by 2519000bps in 2021 and then plummeted by -382100bps in 2023.
  • Over the past 5 years, PROCEPT BioRobotics' FCF Margin (Quarter) stood at 165.79% in 2021, then surged by 32bps to 113.26% in 2022, then surged by 32bps to 76.89% in 2023, then surged by 36bps to 49.19% in 2024, then surged by 77bps to 11.4% in 2025.
  • Its last three reported values are 11.4% in Q3 2025, 22.54% for Q2 2025, and 27.21% during Q1 2025.